A recent report from the Centers for Disease Control and Prevention shows that the number of induced deliveries is on the decline after almost 20 years of increases. The data are taken from the Natality Data File from the National Vital Statistics System and represent births in singleton deliveries, which are the majority of newborns.
A new scanning device-the RF Assure Delivery System-may make manual counting and vaginal sweeps for avoiding retained sponges or gauze a thing of the past.
Pregnant teens are more likely to engage in pica, a behavior characterized by compulsive cravings for nonfood items. Anemia may have something to do with it.
Challenge your diagnostic skills: See anything out of the ordinary in this second trimester fetal heart study?
A new tool better evaluates how well residents are mastering the critical communication skills that make for a good bedside manner.
Bisphosphonates offer women no protection against breast cancer but do help prevent fractures related to osteoporosis.
A prospective Italian study published in The Journal of Clinical Endocrinology & Metabolism suggests that low levels of vitamin D [25(OH)D] may contribute to infertility. The finding, which the authors acknowledge does not confirm causality, could point to possible therapeutic benefits of the vitamin in women undergoing in vitro fertilization (IVF).
Despite earlier observational studies, bisphosphonate treatment for 3 to 4 years appears not to decrease the risk of invasive postmenopausal breast cancer, according to a new study in JAMA Internal Medicine.
According to a new study in Cancer Epidemiology Biomarkers & Prevention, brisk walking or vigorous exercise may help reduce risk of breast cancer in African-American women.
New research may debunk a 20-year practice of prescribing low molecular weight heparin (LMWH) to pregnant patients at risk for blood clots.
A pseudo-tampon that delivers an antiretroviral drug is now being studied as a form of pre-exposure prophylaxis for women at high risk for HIV infection.
Avastin (bevacizumab) has been approved to treat patients with persistent, recurrent, or metastatic cervical cancer by the US Food and Drug Administration (FDA).
Eradicating morcellators is riskier than using them, says the AAGL in a statement for why these minimally invasive devices should not be abandoned.
The FDA has approved bevacizumab (Avastin) for treating persistent, recurrent, or metastatic cervical cancer after studies show gains in overall survival.
Struggling to be fully present at home and at work? Here are 8 tips that have helped one veteran Ob/Gyn in her quest to achieve a satisfactory work-life balance.
A National Cancer Institute-funded case control study suggests that some current formulations of oral contraception (OCs) may increase risk of breast cancer.
Mutations in the PALB2 gene may be associated with a significant increase in the risk of breast cancer, according to a recent study in The New England Journal of Medicine. PALB2 binds to BRCA2-a gene that confers increased lifetime risk of developing breast or ovarian cancer-and likely permits its stable nuclear localization and accumulation.
According to a recent study in Radiology, women older than age 75 may still derive benefits from mammography screening.
Amniocentesis, CVS, noninvasive prenatal testing, microarray . . . the rapid advancements in prenatal genetic testing can be dizzying. These 7 expert tips can help navigate the gamut.
Texts, emails, and voicemails may prove effective in getting surgical patients to follow preadmission instructions aimed at reducing surgical site infections.
Menopausal hot flashes may be more bothersome in women who drink caffeine, according to results of a 6-year cross-sectional survey published in Menopause.
According to a recent study in Annals of Internal Medicine, hormonal therapy in early menopause may improve some markers of cardiovascular disease (CVD) risk, but not progression of atherosclerosis.
A single-institution retrospective study published in JSLS, The Journal of the Society of Laparoendoscopic Surgeons suggests that operative times may be shorter and blood loss lower when hysterectomy is done by high-volume surgeons.
A large insurance company has decided to no longer cover laparoscopic power morcellation. Is this the beginning of the end of power morcellators?
The best-ranked hospitals for gynecology have once again been listed by U.S. News & World Report. We noticed a trend-observational only-and want to know what you think.
Folic acid (vitamin B9) can prevent neural tube defects, but how much is needed to substantially reduce risk? Find out here.
Challenge your diagnostic skills: What’s the source of pain in this middle-aged woman?
Dr. Afshar talks about the onslaught of information that the modern-day doctor faces and how to keep the focus on the patient.
Will cell-free DNA testing replace amniocentesis?
“Dosing of oxytocin and timing of level of increase in dose has been the subject of many scientific publications,” noted study coauthor and Contemporary OB/GYN editorial board member Haywood Brown, MD.